STAT3 signaling in ovarian cancer: a potential therapeutic target
- PMID: 31949487
- PMCID: PMC6959025
- DOI: 10.7150/jca.35011
STAT3 signaling in ovarian cancer: a potential therapeutic target
Abstract
Accumulating evidence has shown that Signal Transducer and Activator of Transcription 3 (STAT3) is thought to be a promising target for cancer therapy as STAT3 is frequently overexpressed in a wide range of cancer cells as well as clinical specimens, promoting tumor progression. It is widely accepted that STAT3 regulates a variety of cellular processes, such as tumor cell growth, survival, invasion, cancer stem cell-like characteristic, angiogenesis and drug-resistance. In this review, we focus on the role of STAT3 in tumorigenesis in ovarian cancer and discuss the existing inhibitors of STAT3 signaling that can be promisingly developed as the strategies for ovarian cancer therapy.
Keywords: STAT3; inhibitors; ovarian cancer; tumorigenesis.
© The author(s).
Conflict of interest statement
Competing Interests: The authors have declared that no competing interest exists.
Figures
![Figure 1](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2355/6959025/6eaffbe99198/jcav11p0837g001.gif)
![Figure 2](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2355/6959025/57f4fe5cd71a/jcav11p0837g002.gif)
![Figure 3](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2355/6959025/0570f1c58a46/jcav11p0837g003.gif)
![Figure 4](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2355/6959025/08102ed8d81b/jcav11p0837g004.gif)
Similar articles
-
CD44 in Ovarian Cancer Progression and Therapy Resistance-A Critical Role for STAT3.Front Oncol. 2020 Dec 1;10:589601. doi: 10.3389/fonc.2020.589601. eCollection 2020. Front Oncol. 2020. PMID: 33335857 Free PMC article. Review.
-
The role of STAT3 signaling in mediating tumor resistance to cancer therapy.Curr Drug Targets. 2014;15(14):1341-53. doi: 10.2174/1389450115666141120104146. Curr Drug Targets. 2014. PMID: 25410411 Review.
-
STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review.J Exp Clin Cancer Res. 2019 May 14;38(1):195. doi: 10.1186/s13046-019-1206-z. J Exp Clin Cancer Res. 2019. PMID: 31088482 Free PMC article.
-
Signal transducer and activator of transcription 3 as a therapeutic target for cancer and the tumor microenvironment.Arch Pharm Res. 2016 Aug;39(8):1085-99. doi: 10.1007/s12272-016-0795-8. Epub 2016 Aug 11. Arch Pharm Res. 2016. PMID: 27515050 Review.
-
The Multifaceted Roles of STAT3 Signaling in the Progression of Prostate Cancer.Cancers (Basel). 2014 Apr 9;6(2):829-59. doi: 10.3390/cancers6020829. Cancers (Basel). 2014. PMID: 24722453 Free PMC article.
Cited by
-
Identification of GNA12-driven gene signatures and key signaling networks in ovarian cancer.Oncol Lett. 2021 Oct;22(4):719. doi: 10.3892/ol.2021.12980. Epub 2021 Aug 10. Oncol Lett. 2021. PMID: 34429759 Free PMC article.
-
Niraparib-induced STAT3 inhibition increases its antitumor effects.Front Oncol. 2022 Oct 17;12:966492. doi: 10.3389/fonc.2022.966492. eCollection 2022. Front Oncol. 2022. PMID: 36324587 Free PMC article.
-
Synthesis and evaluation of [18F]FBNAF, a STAT3-targeting probe, for PET imaging of tumor microenvironment.EJNMMI Radiopharm Chem. 2024 Jun 4;9(1):46. doi: 10.1186/s41181-024-00276-w. EJNMMI Radiopharm Chem. 2024. PMID: 38834900 Free PMC article.
-
pSTAT3 activation of Foxl2 initiates the female pathway underlying temperature-dependent sex determination.Proc Natl Acad Sci U S A. 2024 Sep 10;121(37):e2401752121. doi: 10.1073/pnas.2401752121. Epub 2024 Sep 3. Proc Natl Acad Sci U S A. 2024. PMID: 39226347
-
The Cancer Stem Cell Niche in Ovarian Cancer and Its Impact on Immune Surveillance.Int J Mol Sci. 2021 Apr 15;22(8):4091. doi: 10.3390/ijms22084091. Int J Mol Sci. 2021. PMID: 33920983 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous